Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Sun Pharmaceuticals Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524715NSE Symbol: SUNPHARMAP/E(TTM):154.71
ISIN Demat:INE044A01036Div & Yield %:0.76EPS(TTM):11.49
Book Value(Rs):98.3315118Market Cap ( Cr.):426517.78Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 20275.1720812.1415585.9814116.0512531.9310303.21
Excise Duty0.000.000.000.000.000.00
Net Sales20275.1720812.1415585.9814116.0512531.9310303.21
Other Income 553.48329.291196.88192.071510.921271.44
Stock Adjustments -180.32237.93183.18179.64-138.60251.30
Total Income20648.3321379.3616966.0414487.7613904.2511825.95
EXPENDITURE :      
Raw Materials 5423.796292.095833.575287.124429.123924.56
Power & Fuel Cost450.42495.21422.33384.16394.74407.28
Employee Cost 2373.952156.952000.781805.981702.771571.34
Other Manufacturing Expenses 1195.301037.321064.32862.12860.05898.51
Selling and Administration Expenses 4754.864326.423514.053309.621919.251503.17
Miscellaneous Expenses 615.663257.272086.08479.24375.751707.77
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure14813.9817565.2614921.1312128.249681.6810012.63
Operating Profit5834.353814.102044.912359.524222.571813.32
Interest 784.08472.18388.10267.52408.01540.92
Gross Profit5050.273341.921656.812092.003814.561272.40
Depreciation1600.621600.871349.951236.43561.56552.95
Profit Before Tax3449.651741.05306.86855.573253.00719.45
Tax546.10752.77-553.58244.91386.461.55
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax45.37-702.44960.43-231.74-344.60-98.70
Reported Net Profit2858.181690.72-99.99842.403211.14816.60
Extraordinary Items -193.46-1665.671237.51-63.64193.27-1048.68
Adjusted Net Profit3051.643356.39-1337.50906.043017.871865.28
Adjst. below Net Profit -19.867.38-14.532675.94-211.5210.17
P & L Balance brought forward12790.8813612.0815964.5514005.2712384.6112037.00
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 2898.162519.302237.951559.061378.96479.16
P & L Balance carried down12731.0412790.8813612.0815964.5514005.2712384.61
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1350.001150.001000.00750.00400.00275.00
Earnings Per Share-Unit Curr11.917.05-0.423.5113.383.40
Earnings Per Share(Adj)-Unit Curr11.917.05-0.423.5113.383.40
Book Value-Unit Curr98.7698.98102.48112.28101.6895.21